A fundraising walk in Tempe this weekend will bring together pancreatic cancer patients, survivors, families and medical professionals to raise awareness about one of the deadliest forms of cancer. The third annual Steppin’ Up Against Pancreatic Cancer Walk will take place Saturday, November 14, 2026, at Arizona State University’s Mountain America Stadium, offering participants an opportunity to support cancer research while learning about treatment options and resources available to patients.
The event is organized by the Seena Magowitz Foundation in partnership with HonorHealth. In addition to raising money for research and patient programs, the gathering is designed to connect people affected by pancreatic cancer with healthcare professionals, support services and others facing similar challenges.
For Valley resident Pam Jackson, the event carries personal significance after more than three years of battling pancreatic cancer. Jackson was diagnosed in June 2023, an experience she described as emotionally overwhelming as she struggled to process the seriousness of her condition.
Following her diagnosis, Jackson underwent four months of chemotherapy and surgery involving her pancreas and spleen. The treatments initially brought her cancer into remission, providing relief after months of uncertainty.
However, her condition changed during the summer of 2025 when doctors discovered that the cancer had returned and spread to her liver. The recurrence meant that Jackson was now facing Stage 4 pancreatic cancer, a diagnosis that left her questioning how much time she had remaining.
Pancreatic cancer is particularly difficult to treat because it is frequently discovered after the disease has advanced. According to the American Cancer Society, the disease accounts for approximately 3% of cancer diagnoses in the United States but is responsible for roughly 8% of cancer deaths.
The organization estimates that more than 67,000 Americans will be diagnosed with pancreatic cancer in 2026. The disease has an overall five-year survival rate of approximately 13%, reflecting the challenges patients and physicians face when treatment begins.
Jackson’s outlook began to improve after she enrolled in a clinical trial at the HonorHealth Research Institute in Scottsdale. The trial involved daraxonrasib, an experimental targeted therapy developed to interfere with proteins that help pancreatic cancer cells grow.
Jackson reported significant improvements after beginning the treatment. According to her account, a cancerous mass on her liver decreased in size by 43% over a period slightly longer than one year.
The results provided renewed hope after her cancer had returned at an advanced stage. Jackson said the treatment helped change her perspective from fearing that she had limited time remaining to focusing on living her life and continuing treatment.
The medication she received, daraxonrasib, has since gained national attention as a promising treatment for advanced pancreatic cancer.
On August 26, 2026, the U.S. Food and Drug Administration approved the drug under the brand name Rasonque for certain adults with metastatic pancreatic adenocarcinoma. The approval applies to patients who have already received at least one systemic treatment or are not candidates for particular combination therapies.
Clinical research demonstrated a significant improvement in survival among eligible patients receiving the medication compared with those receiving standard chemotherapy. In a major clinical trial involving 500 participants, median overall survival reached approximately 13.2 months for patients treated with daraxonrasib, compared with 6.7 months for those receiving conventional chemotherapy.
Although the drug is not considered a cure, the findings represent an important development for a disease that has historically offered limited treatment options for patients with advanced cancer.
Erin Pierce, a nurse practitioner and associate clinical investigator at the HonorHealth Research Institute, has worked with Jackson throughout her treatment. Pierce described the emotional significance of seeing patients respond positively to new therapies, particularly when previous treatment options have offered limited success.
For medical professionals involved in cancer research, improvements documented through clinical scans can represent years of scientific work translated into meaningful benefits for patients. Pierce said those moments can be deeply emotional for clinicians who develop close relationships with the individuals receiving care.
Jackson credits both the medical treatment and the support she received throughout the process with helping her maintain a positive outlook. She encourages other patients facing serious diagnoses to remain hopeful and pay attention to their emotional well-being while pursuing appropriate medical care.
Her participation in Saturday’s walk will also be a family occasion. Jackson expects approximately two dozen relatives and friends to join her at Mountain America Stadium, surrounding her with support as she celebrates the progress made during her treatment.
The Steppin’ Up Against Pancreatic Cancer Walk is scheduled to begin at 10 a.m., with registration opening at 9 a.m.
Participants can choose between a family-friendly 100-meter walking route and a 5K course that travels through and around the stadium. Organizers will track and count participants’ steps as a symbol of the collective effort to improve treatment outcomes and support cancer research.
During each of the previous two years, participants collectively recorded more than one million steps in recognition of those affected by pancreatic cancer.
The event will also provide information and resources for patients and caregivers. Available support will include Seena Magowitz Foundation programs, nutritional guidance, patient assistance services and information about social services that may help families navigate the challenges associated with a cancer diagnosis.
Organizers hope the combination of fundraising, education and personal connections will help participants better understand available treatment options while reducing the isolation that patients and caregivers sometimes experience.
The Seena Magowitz Foundation focuses on advancing pancreatic cancer research, increasing public awareness and supporting patients and their families. Its partnership with HonorHealth connects community fundraising efforts with medical research and clinical programs intended to improve outcomes.
For Jackson, Saturday’s gathering represents much more than a walk around a stadium. It is an opportunity to celebrate her progress, recognize the medical professionals who helped her and encourage other families facing pancreatic cancer.
With new treatments providing additional options for certain patients, organizers hope the event will demonstrate how continued research, community involvement and accessible support programs can make a difference for people confronting the disease.
Residents interested in participating can find registration information and additional event details through the Seena Magowitz Foundation.
Source: ABC15 Arizona



